Emory University to Lead Infectious Diseases Clinical Research Consortium Leadership Group
The National Institute of Allergy and Infectious Diseases (NIAID) has selected Emory University to lead a new effort aimed at ...
The National Institute of Allergy and Infectious Diseases (NIAID) has selected Emory University to lead a new effort aimed at ...
The Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) announced that ...
The following statement released on Sept. 19 from the Infectious Diseases Society of America (IDSA) is published here in its ...
NIAID’s Radiation Nuclear Countermeasures Program (RNCP) seeks support to assess current methodology and variations in radiation dosing in in vivo and in vitro studies ...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health seeks to partner with one ...
Tulane University researchers are developing a vaccine formulation that may provide longer lasting immunity in fewer doses against pertussis, more ...
Vaccinations have begun in a first-in-human trial of an experimental Zika virus vaccine, the National Institute of Allergy and Infectious ...
On the left is a 1918 H1 influenza virus-like particle (VLP) as seen by cryo-electron microscopy. On the right is ...
The National Institute of Allergy and Infectious Diseases (NIAID) is developing a strategic framework to advance tuberculosis (TB) research and ...
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat ...
Humanetics Corporation has been awarded a three-year contract valued at approximately $5.4 million from the National Institute of Allergy and ...
The National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) is part of the National Interagency Biodefense ...
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) is seeking proposals from qualified offerors to ...
Prior studies of survivors of the 2014-2016 Ebola outbreak in West Africa have revealed sexual transmission of Ebola virus, and that ...
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...
The high seasonal morbidity and mortality associated with both pandemic and seasonal influenza, the continued threat of highly pathogenic avian ...
The National Institute of Allergy and Infectious Diseases (NIAID) is competing a support contract for scientific, professional and technical expertise ...
A clinical trial of an experimental vaccine to prevent infection with chikungunya virus is now enrolling healthy adult volunteers at ...
The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) is seeking proposals for ...
In response to the threat presented by increasing numbers of infections caused by antimicrobial–resistant (AR) and multidrug-resistant (MDR) Gram-negative bacterial ...